Loading stock data…
LifeStance Health Group (LFST)
$10.34+0.06 (+0.58%)
After Hours$10.34+0.00 (+0.00%)· Last close Jun 29
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
LifeStance Health Group, Inc. in the Healthcare sector is trading at $10.34 with a market capitalization of $3.3B. Wall Street consensus targets $10.55 (10 analysts), implying a +2.0% move over the next 12 months. The stock is currently near its 52-week high of $10.63, remaining 52.7% above its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $403.48M↑ | $382.19M↑ | $363.81M↑ | $345.31M↑ | $332.97M |
| Gross Profit | $135.93M↑ | $126.30M↑ | $116.58M↑ | $108.43M↓ | $109.79M |
| Operating Income | $22.28M↑ | $18.08M↑ | $7.41M↑ | -$2.95M↓ | $1.60M |
| Net Income | $14.24M↑ | $11.67M↑ | $1.08M↑ | -$3.79M↓ | $709,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.32B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.57%
Volume
Today's trading volume
4.56M
Recent News
1 Russell 2000 Stock for Long-Term Investors and 2 We Ignore
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
2 Profitable Stocks Worth Investigating and 1 Facing Challenges
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.
4 Outpatient Home Health Stocks Benefiting From Industry Trends
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.